Skip to content

13F-HR filed by Casdin Capital, LLC

Casdin Capital, LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 33 holding rows worth $1,098,157,889.

Accession
0000919574-25-004903
Filed
2025-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 33 entries on the cover page, a total value of $1,098,157,889 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,098,157,889 with VALUE read as dollars as filed, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GENEDX HOLDINGS CORP81663L200COM CL A3,507,164$323,746,309dollars as filed
BIOLIFE SOLUTIONS INC COM NEW09062W204Stock7,707,165$166,012,334dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock2,887,933$106,247,055dollars as filed
STANDARD BIOTOOLS INC34385P108COM76,075,636$91,290,763dollars as filed
ILLUMINA INC452327109COM645,000$61,539,450dollars as filed
AVIDITY BIOSCIENCES INC COM05370A108Stock1,775,000$50,410,000dollars as filed
VERVE THERAPEUTICS INC92539P101COM4,095,571$45,993,262dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock11,398,574$39,439,066dollars as filed
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock81,500$26,576,335dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY1,225,000$25,406,500dollars as filed
BEAM THERAPEUTICS INC07373V105COM1,450,000$24,664,500dollars as filed
NEUROGENE INC64135M105COMMON STOCK1,295,361$19,365,647dollars as filed
CODEXIS INC192005106COM7,200,000$17,568,000dollars as filed
SAREPTA THERAPEUTICS INC803607100COM990,097$16,930,659dollars as filed
DENALI THERAPEUTICS INC COM24823R105Stock890,000$12,451,100dollars as filed
HIMS & HERS HEALTH INC433000106COM CL A230,000$11,465,500dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock758,857$9,311,175dollars as filed
VERACYTE INC COM92337F107Stock276,308$7,468,605dollars as filed
Eli Lilly and Company532457108COM8,500$6,626,005dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM650,000$6,084,000dollars as filed
SEPTERNA INC COM81734D104Stock553,268$5,848,043dollars as filed
GUARDANT HEALTH INC COM40131M109Stock100,000$5,204,000dollars as filed
EXACT SCIENCES CORP COM30063P105Stock90,000$4,782,600dollars as filed
PRIME MEDICINE INC74168J101COM1,567,175$3,870,922dollars as filed
AGIOS PHARMACEUTICALS INC00847X104COM100,000$3,326,000dollars as filed
ABSCI CORPORATION00091E109COM973,260$2,501,278dollars as filed
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock723,767$897,471dollars as filed
RECURSION PHARMACEUTICALS IN75629V104CL A165,323$836,534dollars as filed
CENTURY THERAPEUTICS INC15673T100COM1,228,190$686,190dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock148,333$588,882dollars as filed
GINKGO BIOWORKS HOLDINGS INC37611X209COMMON STOCK36,493$410,546dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM86,014$387,923dollars as filed
TENAYA THERAPEUTICS INC87990A106COM361,969$221,235dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-25-004903this filing2025-08-14acceptance time not in the bulk data set